Blog
Blog
Health Care and Life Science at HBS
Health Care and Life Science at HBS
Kasite Ugo-beke’s journey from Nigeria to Harvard Business School is a testament to the power of passion and purpose in healthcare innovation. From early experiences witnessing healthcare gaps to exploring the intersection of science and business, her time at HBS has reignited her drive to create meaningful, scalable impact. [...]
Globally, there are about 350 million people, or 8% of the population, with a rare disease, yet only 5% of these diseases have an approved therapy. It’s a dilemma that is historically overlooked, largely because it’s hard to make a profit from a treatment that affects so few people. How do we empower patients with rare diseases when a lack of treatment options and awareness can result in significant health complications? [...]
Right now in the United States, at least 50 million women are entering menopause, and a recent survey has shown a majority of them face a lack of care, treatment, and support from their existing providers, and a sense of isolation. What can leaders, entrepreneurs, investors, etc. do to give the female workforce the tools to thrive during this important health journey? [...]
As an HBS student in Professor Vicki Sato’s Commercializing Science class, I wanted to tackle an unmet global health care need by applying my engineering and business skills to a solvable problem. Working with my co-founders, we saw an opportunity to supply much-needed vaccines worldwide without refrigeration or cold storage using silk. [...]
As investors and advocates in women’s health, we view the recent SCOTUS decision in Dobbs v. Jackson Women’s Health Organization, which overturned Roe v. Wade, as a significant step back in women’s health and rights. Now is the time to capitalize on the growing momentum in women’s health innovation and investment to meet new and existing gaps in care. [...]
Load More Loading...